Axsome Therapeutics, Inc.
AXSM
$210.63
$2.811.35%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 319.85M | 305.11M | 322.93M | 325.27M | 303.02M |
| Total Receivables | 277.46M | 251.06M | 224.46M | 196.51M | 198.83M |
| Inventory | 37.88M | 31.52M | 27.94M | 23.77M | 18.44M |
| Prepaid Expenses | 21.38M | 23.52M | 13.65M | 19.79M | 16.34M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 656.57M | 611.21M | 588.99M | 565.34M | 536.62M |
|
|
|||||
| Total Current Assets | 656.57M | 611.21M | 588.99M | 565.34M | 536.62M |
| Net Property, Plant & Equipment | 20.03M | 20.58M | 21.42M | 22.26M | 23.14M |
| Long-term Investments | 12.04M | 12.04M | 12.04M | 12.04M | 12.04M |
| Goodwill | 12.04M | 12.04M | 12.04M | 12.04M | 12.04M |
| Total Other Intangibles | 37.36M | 38.95M | 40.52M | 42.13M | 43.73M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 35.45M | 30.83M | 26.84M | 27.48M | 24.25M |
| Total Assets | 761.45M | 713.61M | 689.81M | 669.25M | 639.79M |
|
|
|||||
| Total Accounts Payable | 78.97M | 106.70M | 65.54M | 54.23M | 91.63M |
| Total Accrued Expenses | 294.15M | 247.44M | 230.21M | 223.14M | 168.89M |
| Short-term Debt | 70.00M | 70.00M | 70.00M | 70.00M | 70.00M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.13M | 3.82M | 2.98M | 3.23M | 2.35M |
| Total Finance Division Other Current Liabilities | 11.20M | 11.25M | 10.11M | 9.70M | 9.23M |
| Total Other Current Liabilities | 11.20M | 11.25M | 10.11M | 9.70M | 9.23M |
| Total Current Liabilities | 460.45M | 439.21M | 378.84M | 360.29M | 342.10M |
|
|
|||||
| Total Current Liabilities | 460.45M | 439.21M | 378.84M | 360.29M | 342.10M |
| Long-Term Debt | 117.96M | 117.85M | 117.75M | 117.64M | 117.54M |
| Short-term Debt | 70.00M | 70.00M | 70.00M | 70.00M | 70.00M |
| Capital Leases | 30.60M | 28.23M | 27.39M | 27.72M | 27.42M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 69.14M | 73.73M | 77.54M | 89.87M | 79.66M |
| Total Liabilities | 678.14M | 659.02M | 601.51M | 595.52M | 566.71M |
|
|
|||||
| Common Stock & APIC | 1.51B | 1.43B | 1.39B | 1.35B | 1.30B |
| Retained Earnings | -1.42B | -1.37B | -1.31B | -1.28B | -1.23B |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 83.30M | 54.59M | 88.30M | 73.73M | 73.08M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 83.30M | 54.59M | 88.30M | 73.73M | 73.08M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 83.30M | 54.59M | 88.30M | 73.73M | 73.08M |
|
|
|||||